Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Salestools Logo

Salestools

#1 AI-agent til salgsteams og Go-to-Market-teams. Sælg mere, hurtigere, med mindre indsats.

Produkt

  • AI-salgsagenter
  • Intent-data
  • Teknologidata
  • Besøgssporing
  • Co-Pilot
  • Socialt salg

Løsninger

  • Kundeservice
  • E-handel
  • SaaS
  • Enterprise
  • Lille virksomhed

Ressourcer

  • Rapporten
  • Dokumentation
  • API-reference
  • Hjælpecenter
  • Blog
  • Case-studier
  • Webinarer

Virksomhed

  • Om os
  • Karriere
  • Presse
  • Kontakt
  • Partnere

Vores lokationer

  • New York, HQ
  • Bukarest, AI-forskningslaboratorium
  • Zug, Schweiz

© 2026 Salestools. Alle rettigheder forbeholdes.

Datavilkår & sikkerhedPrivatlivspolitikServicevilkårAcceptable Use
Alle systemer operationelle
Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Back to Reports
Fundraising

Helicone

Helicone Raises $5M in Seed

548 Market Street, San Francisco, CA 94104September 13, 20242 min read
Employees
10+

Helicone Raises $5M in Seed


Helicone has successfully raised $5M in a Seed at a $25M valuation led by YC Combinator, Village Global, FundersClub.


Company Overview


Helicone is a AI/ML company headquartered in 548 Market Street, San Francisco, CA 94104, founded in 2023 with 10+ employees.


LLM observability platform


Fundraising Details


  • Amount Raised: $5M
  • Round Type: Seed
  • Valuation: $25M
  • Date: 2024-09-13
  • Investors: YC Combinator, Village Global, FundersClub

About Helicone


LLM observability platform The company is positioned in the AI/ML sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 548 Market Street, San Francisco, CA 94104
  • Founded: 2023
  • Team Size: 10+
  • Industry: AI/ML

What This Means


This funding round demonstrates strong investor confidence in Helicone's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The AI/ML sector continues to attract significant investment as companies innovate to meet evolving market demands. Helicone's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $25M valuation marks an important milestone for Helicone, positioning the company among notable players in the AI/ML industry.


Looking Ahead


With this new capital, Helicone is well-positioned to execute on its growth strategy and continue building innovative solutions in the AI/ML space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-09-13. For more information about Helicone, visit their headquarters at 548 Market Street, San Francisco, CA 94104.

Company Info

Headquarters
548 Market Street, San Francisco, CA 94104
Founded
2023
Team Size
10+

Topics

Fundraising(2912)AI/ML(484)SeedHelicone

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free